R
Richard J Marsden
Researcher at Southampton General Hospital
Publications - 2
Citations - 495
Richard J Marsden is an academic researcher from Southampton General Hospital. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 2, co-authored 2 publications receiving 389 citations.
Papers
More filters
Journal ArticleDOI
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
Phillip Monk,Richard J Marsden,Victoria Tear,Jody Brookes,Toby N Batten,Marcin Mankowski,Felicity J Gabbay,Donna E. Davies,Stephen T. Holgate,Stephen T. Holgate,Ling-Pei Ho,Tristan W Clark,Ratko Djukanovic,Tom Wilkinson,Michael G. Crooks,Davinder Dosanjh,Salman Siddiqui,Najib M. Rahman,Jacklyn A Smith,Alex Horsley,Tim Harrison,Dinesh Saralaya,Lorcan McGarvey,Alastair Watson,Edmund Foster,Adam Fleet,Dave Singh,Sophie Hemmings,Sandra Aitken,Sarah Dudley,Rona Beegan,Angela Thompson,Pedro Mb Rodrigues +32 more
TL;DR: Patients who received SNG001 had greater odds of improvement and recovered more rapidly from SARS-CoV-2 infection than patients who received placebo, providing a strong rationale for further trials.
Journal ArticleDOI
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.
Ratko Djukanovic,Tim Harrison,Sebastian L. Johnston,Flic Gabbay,Peter A. B. Wark,Neil C. Thomson,Robert Niven,Dave Singh,Helen K. Reddel,Donna E. Davies,Richard J Marsden,Christine B. Boxall,Sarah Dudley,Vincent Plagnol,Stephen T. Holgate,Phillip Monk +15 more
TL;DR: It is suggested that inhaled IFN-β is a potential treatment for virus-induced deteriorations of asthma in difficult-to-treat people with asthma and supports the need for further, adequately powered, trials in this population.